Chylothorax After Esophagectomy for Esophageal Cancer: Risk Factors and Management

Overview

Journal Indian J Gastroenterol

Specialty Gastroenterology

Date 2015 Jun 2

PMID 26027841

Citations 11

Authors

Rahul Gupta

Harjeet Singh

Saurabh Kalia

Rajesh Gupta

Rajinder Singh

G R Verma

Affiliations

Soon will be listed here.

Abstract

Background: Chylothorax is an uncommon complication of esophagectomy. It carries significant morbidity and mortality. The predisposing factors are ill-defined.

Methods: We retrospectively evaluated the data of 45 patients of carcinoma esophagus who underwent esophagectomy after neoadjuvant chemoradiotherapy (NACRT) from January 2010 to July 2012 in our tertiary health care center.

Results: Four patients (8.88 %) had chylothorax. On analysis of perioperative factors, it was found that patients with chylothorax had tumor in middle third of thoracic esophagus (100 %), shown partial response to neoadjuvant chemoradiation (NACRT) (100 %) and were associated with difficult mediastinal dissection (75 %) leading to higher blood loss requiring transfusion unlike those without chylothorax. There was no significant difference in the incidence of chylothorax following transhiatal, 3/35 = 8.57 % or transthoracic esophagectomy 1/10 = 10 % (p = 0.898). Three patients were managed by transabdominal en masse ligation of tissue between aorta and azygos vein while one patient was managed conservatively. Patients were discharged after a mean hospital stay of 15.5 days. The 30-day mortality rates in the two groups were similar (0 % vs. 4.8 %).

Conclusion: Difficult mediastinal dissection during esophagectomy in middle esophageal cancer may lead to thoracic duct injury. Complete response to NACRT may reduce the risk of chylothorax. Early transabdominal en masse ligation carries excellent results. Low output fistula following thoracic duct injury can be managed conservatively.

Citing Articles

Esophagectomy in patients with liver cirrhosis: systematic review and meta-analysis of short-term outcomes.

Sozzi A, Aiolfi A, Bonitta G, Bona D, Bonavina L, Biondi A Updates Surg. 2024; 77(1):143-152.

PMID: 39718689 DOI: 10.1007/s13304-024-02060-6.

Risk Factors and Treatment of Chylothorax After Minimally Invasive Esophagectomy for Esophageal Cancer.

Tsuchitani Y, Ozawa Y, Taniyama Y, Okamoto H, Sato C, Ishida H Cureus. 2024; 16(7):e65606.

PMID: 39205723 PMC: 11350151. DOI: 10.7759/cureus.65606.

Incidence of chylothorax over nineteen years of transhiatal esophagectomy: A case series and review study.

Mahmodlou R, Yousefiazar A Turk J Surg. 2023; 38(4):401-408.

PMID: 36875269 PMC: 9979556. DOI: 10.47717/turkjsurg.2022.5821.

The management of chyle leak post-oesophagectomy for oesophageal carcinoma: a systematic review.

Robinson A, Kennedy L, Roper T, Khan M, Jaunoo S Ann R Coll Surg Engl. 2021; 104(7):480-489.

PMID: 34860128 PMC: 9246555. DOI: 10.1308/rcsann.2021.0199.

Management of chyle leakage after general thoracic surgery: Impact of thoracic duct embolization.

Jeon Y, Cho J, Hyun D, Shin S, Kim H, Choi Y Thorac Cancer. 2021; 12(9):1382-1386.

PMID: 33783956 PMC: 8088932. DOI: 10.1111/1759-7714.13914.

References

Rindani R, Martin C, Cox M . Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?. Aust N Z J Surg. 1999; 69(3):187-94. DOI: 10.1046/j.1440-1622.1999.01520.x. View

Laug W, DeClerck Y, Jones P . Degradation of the subendothelial matrix by tumor cells. Cancer Res. 1983; 43(4):1827-34. View

Shah R, Luketich J, Schuchert M, Christie N, Pennathur A, Landreneau R . Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg. 2012; 93(3):897-903. PMC: 3430511. DOI: 10.1016/j.athoracsur.2011.10.060. View

Merigliano S, Molena D, Ruol A, Zaninotto G, Cagol M, Scappin S . Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg. 2000; 119(3):453-7. DOI: 10.1016/s0022-5223(00)70123-1. View

Hulscher J, van Sandick J, de Boer A, Wijnhoven B, Tijssen J, Fockens P . Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002; 347(21):1662-9. DOI: 10.1056/NEJMoa022343. View

Kumar S, Kumar A, Pawar D . Thoracoscopic management of thoracic duct injury: Is there a place for conservatism?. J Postgrad Med. 2004; 50(1):57-9. View

Schumacher G, Weidemann H, Langrehr J, Jonas S, Mittler J, Jacob D . Transabdominal ligation of the thoracic duct as treatment of choice for postoperative chylothorax after esophagectomy. Dis Esophagus. 2007; 20(1):19-23. DOI: 10.1111/j.1442-2050.2007.00636.x. View

Stone H, Coleman C, Anscher M, McBride W . Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003; 4(9):529-36. DOI: 10.1016/s1470-2045(03)01191-4. View

Rao D, Chava S, Sahni P, Chattopadhyay T . Thoracic duct injury during esophagectomy: 20 years experience at a tertiary care center in a developing country. Dis Esophagus. 2004; 17(2):141-5. DOI: 10.1111/j.1442-2050.2004.00391.x. View

10.

Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K . Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res. 2003; 159(3):283-300. DOI: 10.1667/0033-7587(2003)159[0283:sariao]2.0.co;2. View

11.

Lai F, Chen L, Tu Y, Lin M, Li X . Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg. 2011; 91(6):1770-4. DOI: 10.1016/j.athoracsur.2011.02.070. View

12.

Mishra P, Saluja S, Ramaswamy D, Bains S, Haque P . Thoracic duct injury following esophagectomy in carcinoma of the esophagus: ligation by the abdominal approach. World J Surg. 2012; 37(1):141-6. DOI: 10.1007/s00268-012-1811-x. View

13.

STONE H, Milas L . Enhancement of radiation-induced normal tissue damage by a fibrosarcoma. Int J Radiat Oncol Biol Phys. 1987; 13(11):1721-4. DOI: 10.1016/0360-3016(87)90169-6. View

14.

Mason P, Ragoowansi R, Thorpe J . Post-thoracotomy chylothorax--a cure in the abdomen?. Eur J Cardiothorac Surg. 1997; 11(3):567-70. DOI: 10.1016/s1010-7940(96)01120-7. View

15.

Dvorak H . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650-9. DOI: 10.1056/NEJM198612253152606. View

16.

Wirth W, Frommhold H . [Thoracic duct and its variations. Lymphography studies]. Fortschr Geb Rontgenstr Nuklearmed. 1970; 112(4):450-9. View

17.

Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T . Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol. 2002; 12(1 Suppl 1):26-33. DOI: 10.1053/srao.2002.31360. View

18.

Merritt R, Whyte R, DArcy N, Hoang C, Shrager J . Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation. Ann Thorac Surg. 2011; 92(6):2034-40. DOI: 10.1016/j.athoracsur.2011.05.121. View

19.

Hou X, Fu J, Wang X, Zhang L, Liu Q, Luo K . Prophylactic thoracic duct ligation has unfavorable impact on overall survival in patients with resectable oesophageal cancer. Eur J Surg Oncol. 2014; 40(12):1756-62. DOI: 10.1016/j.ejso.2014.05.002. View

20.

Johnstone D, Feins R . Chylothorax. Chest Surg Clin N Am. 1994; 4(3):617-28. View